Microbix Biosystems (TSE:MBX) Trading Down 13.2% – What’s Next?

Microbix Biosystems Inc. (TSE:MBX) shares fell 13.2% on Thursday . The company traded as low as C$0.23 and last traded at C$0.23. 173,500 shares were traded during mid-day trading, an increase of 206% from the average session volume of 56,636 shares. The stock had previously closed at C$0.27.

Microbix Biosystems Price Performance

The company has a debt-to-equity ratio of 30.47, a quick ratio of 5.57 and a current ratio of 7.51. The business has a 50 day simple moving average of C$0.24 and a 200-day simple moving average of C$0.24. The firm has a market cap of C$30.48 million, a price-to-earnings ratio of -7.33 and a beta of 0.48.

Microbix Biosystems (TSE:MBX) last issued its quarterly earnings data on Thursday, May 14th. The company reported C($0.01) EPS for the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%.The company had revenue of C$3.38 million during the quarter. Equities research analysts expect that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.